Abstract
AbstractThe rise in additive manufacturing (AM) offers myriad opportunities for 3D-printed polymeric vascular scaffolds, such as customization and on-the-spot manufacturing,in vivobiodegradation, incorporation of drugs to prevent restenosis, and visibility under X-ray. To maximize these benefits, informed scaffold design is critical. Polymeric bioresorbable vascular scaffolds (BVS) must undergo significant deformation prior to implantation in a diameter-reduction process known as crimping which enables minimally invasive surgery. Understanding the behavior of vascular scaffolds in this step provides twofold benefits: first, it ensures the BVS is able to accommodate stresses occurring during this process to prevent failure, and further, it provides information on the radial strength of the BVS, a key metric to understanding its post-implant performance in the artery. To capitalize on the fast manufacturing speed AM provides, a low time cost solution for understanding scaffold performance during this step is necessary. Through simulation of the BVS crimping process in ABAQUS using experimentally obtained bulk material properties, we have developed a qualitative analysis tool which is capable of accurately comparing relative performance trends of varying BVS designs during crimping in a fraction of the time of experimental testing, thereby assisting in the integration of informed design into the additive manufacturing process.
Publisher
Cold Spring Harbor Laboratory
Reference26 articles.
1. Cleveland Clinic. Peripheral Artery Disease. https://my.clevelandclinic.org/health/diseases/17357-peripheral-artery-disease-pad, accessed: April, 2022.
2. U.S. Food & Drug Administration. Class 1 Device Recall Absorb Bioresorbable Vascular Scaffold (BVS) System. https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfres/res.cfm?id=155009, accessed: October, 2023.
3. A comparative study of restenosis rates in bare metal and drug-eluting stents
4. Oxidative stress changes after stent implantation: A randomized comparative study of sirolimus-eluting and bare metal stents